Metabolic Syndrome in Patients With Coronary Heart Disease. Results of Using Different Diagnostic Criteria

Mijares, Antonio Hernández; Fortuny, Concepción Riera; Triguero, M. L. Martínez; Ariño, Carlos Morillas; Cascales, P; Suárez-Varela, María Morales

doi:10.1016/s1885-5857(06)60655-5

Cited by 5 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The NCEP-ATP Ⅲ definitions differed from WHO and European Group for the study of Insulin Resistance definitions in that insulin resistance is not necessary for diagnostic. In 2005, the IDF published other criteria to define the MS which proposed abdominal obesity as the essential components of the diagnosis of MS, abdominal obesity (Europe men: ≥ 94 cm, Europe women ≥ 80 cm and for Asian men: ≥ 90 cm, Asian women ≥ 80 cm), arterial hypertension (≥ 130/85 mmHg), fasting glycaemia (≥ 100 mg/dL), HDL-C values (< 40 mg/dL in males and < 50 mg/dL in females) and hypertriglyceridemia (≥ 150 mg/dL) [69][70][71][72] . The American Heart Association/National Heart Lung and Blood Institute (AHA/NHLBI) published a new set of criteria of MS that abdominal obesity is not required as a risk factor.…”

Section: Diabetes Mellitusmentioning

confidence: 99%

Non-alcohol fatty liver disease in Asia: Prevention and planning

Ashtari

Pourhoseingholi

Zali

2015

WJH

View full text Add to dashboard Cite

AIM:To review all of epidemiological aspects of nonalcoholic fatty liver disease (NAFLD) and also prevent this disease is examined. METHODS:We conducted a systematic review according to the PRISMA guidelines. All searches for writing this review is based on the papers was found in PubMed (MEDLINE), Cochrane database and Scopus in August and September 2014 for topic of NAFLD in Asia and the way of prevention of this disease, with no language limitations. All relevant articles were accessed in full text and all relevant materials was evaluated and reviewed. RESULTS:NAFLD is the most common liver disorder in worldwide, with an estimated with 20%-30% prevalence in Western countries and 2%-4% worldwide. The prevalence of NAFLD in Asia, depending on location (urban vs rural), gender, ethnicity, and age is variable between 15%-20%. According to the many studies in the world, the relationship between NAFLD, obesity, diabetes mellitus, and metabolic syndrome (MS) is quiet obvious. Prevalence of NAFLD in Asian countries seems to be lower than the Western countries but, it has increased recently due to the rise of obesity, type 2 diabetes and MS in this region. One of the main reasons for the increase in obesity, diabetes and MS in Asia is a lifestyle change and industrialization. Today, NAFLD is recognized as a major chronic liver disease in Asia. Therefore, prevention of this disease in Asian countries is very important and the best strategy for prevention and control of NAFLD is lifestyle modifications. Lifestyle modification programs are typically designed to change bad eating habits and increase physical activity that is associated with clinically significant improvements in obesity, type 2 diabetes and MS. Non-alcohol fatty liver disease in Asia: Prevention and planning in Asian countries particularly in Arab countries because of high prevalence of obesity, diabetes and MS. CONCLUSION: Prevention of NAFLD is very important SYSTEMATIC REVIEWS

show abstract

Section: Diabetes Mellitusmentioning

confidence: 99%